PE28191A1 - Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas - Google Patents

Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas

Info

Publication number
PE28191A1
PE28191A1 PE1990177640A PE17764090A PE28191A1 PE 28191 A1 PE28191 A1 PE 28191A1 PE 1990177640 A PE1990177640 A PE 1990177640A PE 17764090 A PE17764090 A PE 17764090A PE 28191 A1 PE28191 A1 PE 28191A1
Authority
PE
Peru
Prior art keywords
growth factor
expression
procedure
nervous growth
cells
Prior art date
Application number
PE1990177640A
Other languages
English (en)
Spanish (es)
Inventor
Valle Francesco Della
Alessandro Negro
Lanfranco Callegaro
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of PE28191A1 publication Critical patent/PE28191A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Plant Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE1990177640A 1989-11-16 1990-11-15 Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas PE28191A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04856489A IT1238348B (it) 1989-11-16 1989-11-16 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.

Publications (1)

Publication Number Publication Date
PE28191A1 true PE28191A1 (es) 1991-10-28

Family

ID=11267348

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1990177640A PE28191A1 (es) 1989-11-16 1990-11-15 Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas

Country Status (22)

Country Link
US (1) US5457034A (enExample)
EP (1) EP0432510B1 (enExample)
JP (2) JP3121611B2 (enExample)
KR (1) KR910009929A (enExample)
CN (1) CN1051934A (enExample)
AR (1) AR246983A1 (enExample)
AT (1) ATE214735T1 (enExample)
CA (1) CA2030108C (enExample)
DE (1) DE69033937T2 (enExample)
ES (1) ES2173856T3 (enExample)
FI (1) FI905691L (enExample)
HU (1) HUT61047A (enExample)
IE (1) IE904120A1 (enExample)
IL (1) IL96347A (enExample)
IT (1) IT1238348B (enExample)
NZ (1) NZ236058A (enExample)
PE (1) PE28191A1 (enExample)
PL (1) PL287811A1 (enExample)
PT (1) PT95911B (enExample)
TW (1) TW205069B (enExample)
YU (1) YU217890A (enExample)
ZA (1) ZA909122B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169762A (en) * 1983-03-03 1992-12-08 Genentech, Inc. Human nerve growth factor by recombinant technology
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
AU1447600A (en) * 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
ES2316354T3 (es) 1999-09-29 2009-04-16 The General Hospital Corporation Derivados polipeptidos de la hormona paratiroidea (pth).
US6696238B2 (en) 2000-07-28 2004-02-24 Christopher J. Murphy Transplant media
US7572765B2 (en) * 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
AU2003220380A1 (en) 2003-03-19 2004-11-19 Bristol-Myers Squibb Company CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH Alpha-HELIX STABILIZERS
JP4871128B2 (ja) 2003-07-17 2012-02-08 ザ ジェネラル ホスピタル コーポレイション 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
CN101260398B (zh) 2007-03-07 2013-06-05 舒泰神（北京）生物制药股份有限公司 神经生长因子基因定位改造动物及其制备方法和应用
BRPI0814962B8 (pt) 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
CN101927012B (zh) * 2009-06-26 2013-08-14 丽珠医药集团股份有限公司 神经生长因子的病毒灭活方法
US9492508B2 (en) 2010-05-13 2016-11-15 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
CN102816766A (zh) * 2012-05-04 2012-12-12 沈阳医学院 蛇毒神经生长因子活性多肽的筛选方法
US20240018481A1 (en) * 2021-07-30 2024-01-18 Chengdu Unovel Biopharma Co., Ltd. Recombinant cho cell, construction method therefor, and detection system and method using same
CN115894705A (zh) * 2021-09-30 2023-04-04 三生国健药业（上海）股份有限公司 一种β-NGF融合蛋白、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4796580A (en) * 1987-09-11 1989-01-10 Allied-Signal Inc. Idle control valve for use with a throttle assembly of an internal combustion engine
JPH01211490A (ja) * 1988-02-19 1989-08-24 Tosoh Corp ヒト神経成長因子遺伝子セグメント
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
CN1051934A (zh) 1991-06-05
US5457034A (en) 1995-10-10
IE904120A1 (en) 1991-05-22
JPH03224490A (ja) 1991-10-03
EP0432510A1 (en) 1991-06-19
IT1238348B (it) 1993-07-13
CA2030108C (en) 1998-04-28
HUT61047A (en) 1992-11-30
ATE214735T1 (de) 2002-04-15
NZ236058A (en) 1993-04-28
IL96347A (en) 1997-11-20
ZA909122B (en) 1991-09-25
DE69033937T2 (de) 2002-11-14
IL96347A0 (en) 1991-08-16
JP2001000194A (ja) 2001-01-09
HU907174D0 (en) 1991-05-28
PL287811A1 (en) 1991-12-02
PT95911B (pt) 1998-01-30
AU6655890A (en) 1991-05-23
JP3121611B2 (ja) 2001-01-09
AR246983A1 (es) 1994-10-31
FI905691A7 (fi) 1991-05-17
EP0432510B1 (en) 2002-03-20
DE69033937D1 (de) 2002-04-25
YU217890A (sh) 1993-05-28
PT95911A (pt) 1991-09-13
FI905691L (fi) 1991-05-17
KR910009929A (ko) 1991-06-28
IT8948564A0 (it) 1989-11-16
CA2030108A1 (en) 1991-05-17
TW205069B (enExample) 1993-05-01
FI905691A0 (fi) 1990-11-16
AU645998B2 (en) 1994-02-03
ES2173856T3 (es) 2002-11-01
IT8948564A1 (it) 1991-05-16

Similar Documents

Publication Publication Date Title
PE28191A1 (es) Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas
ES2093025T3 (es) Produccion del factor de crecimiento de celulas endoteliales y adn de codificacion del mismo.
ES2094159T3 (es) Produccion de factor de crecimiento de celulas endoteliales vasculares.
ES2073327T3 (es) Gen y proteina inducida por tgf-beta.
DE69024291D1 (de) Rezeptoren für Tumornekrosisfaktor-alpha und -beta
DE3856238D1 (de) DNA, die für Proteine kodiert, die menschliches IL-1 binden
ES8506089A1 (es) Un procedimiento para preparar una celula u organismo recombinante
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
ATE195148T1 (de) Prozess zur rekombinanten herstellung von hiv-2 - proteinen sowie zellen, die hiv-2 - proteine exprimiert
ATE43636T1 (de) Hefe-hybridvektoren und ihre verwendung fuer die herstellung von polypeptiden.
DE69132937D1 (de) Typ-II-Interleukin-1-Rezeptoren
BR8703269A (pt) Adn ou arn substancialmente puro;celulas contendo adn ou arn;processo para a expressao de eritropoietina humana recombinante biologicamente ativa;eritropoietina humana
PT1318198E (pt) Processo para produzir um polipeptido recombinante que envolve a adicao de um inibidor de quimotripsina ao meio de cultura celular
DE69030539D1 (de) Wachstumsfaktor aus parenchymalen Lebenszellen, dafür kodierendes Gen, Verfahren zur Herstellung dieses Faktors und Transformanten
DE69016508D1 (de) Interleukin-7-Rezeptoren.
ATE142264T1 (de) Rekombinante herstellung von a-ketten- polypeptiden von pdgf
EP0835661A3 (en) Human interferon-Beta2A for use as a medicament
ATE282691T1 (de) Chemokin typ cc-ahnliches protein
JPS55131399A (en) Cultivation of namalva cell and replacing animal serum protein by human albumine for producing interferon by said cell
DE3880032D1 (de) Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen.
FI904789A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen, olennaisesti puhtaan polypeptidin valmistamiseksi
MX9203409A (es) Proteinas bcrfi como inhibidores de la gama interferona.
ATE220690T1 (de) Katze-maus-heterohybridoma und genfragment, das für die konstant-region von katze-immunoglobulin codiert
BR9404991A (pt) Processos para aumentar a produção de proteína C e para aumentar o nível de gama-carboxiliação de uma molécula de proteína C
ATE139568T1 (de) Achromobacter-protease-i-gen sowie genprodukt